Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00385827
What this trial is testing

A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)

Who this might be right for
Cancer, Prostate
Centocor, Inc. 106
Early research (Phase 1)Study completedNCT00559429
What this trial is testing

Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13
Testing effectiveness (Phase 2)Study completedNCT00005857
What this trial is testing

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00541281
What this trial is testing

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Who this might be right for
Hormone Resistant Prostate CancerMetastatic Prostate Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 150
Testing effectiveness (Phase 2)Study completedNCT00052845
What this trial is testing

Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 80
Testing effectiveness (Phase 2)Study completedNCT00675545
What this trial is testing

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients

Who this might be right for
Hormone-Refractory Prostate Cancer
National University Hospital, Singapore 2
Testing effectiveness (Phase 2)Study completedNCT01796028
What this trial is testing

Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Centre Antoine Lacassagne 100
Early research (Phase 1)Study completedNCT00302471
What this trial is testing

MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 29
Large-scale testing (Phase 3)Study completedNCT00110214
What this trial is testing

Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
National Cancer Institute (NCI) 1,050
Early research (Phase 1)Study completedNCT03076203
What this trial is testing

Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneStage IV Prostate AdenocarcinomaHormone-refractory Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Study completedNCT00004149
What this trial is testing

Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 37
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Testing effectiveness (Phase 2)Study completedNCT00038168
What this trial is testing

Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Large-scale testing (Phase 3)WithdrawnNCT00043212
What this trial is testing

Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.

Who this might be right for
Prostate Cancer
Northwest Biotherapeutics
Early research (Phase 1)UnknownNCT00005992
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00193232
What this trial is testing

Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 50
Testing effectiveness (Phase 2)UnknownNCT00795171
What this trial is testing

Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Medical University of Vienna 60
Testing effectiveness (Phase 2)Study completedNCT00140400
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 50
Early research (Phase 1)Study completedNCT01144897
What this trial is testing

PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

Who this might be right for
Castrate Resistant Prostate CancerProstate Cancer
Daniel Vaena 5
Next Page